The Protective Mechanism of TFAM on Mitochondrial DNA and its Role in Neurodegenerative Diseases

被引:15
作者
Song, Ying [1 ,2 ]
Wang, Wenjun [1 ]
Wang, Beibei [1 ]
Shi, Qiwen [1 ]
机构
[1] Zhejiang Univ Technol, Dept Pharmacol, Hangzhou 310014, Zhejiang, Peoples R China
[2] Hangzhou Kings Biopharmaceut Technol Co Ltd, Hangzhou 310007, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Mitochondrial transcription factor A; Mitochondria; Mitochondrial DNA; Neurodegenerative diseases; TRANSCRIPTION FACTOR; MOUSE MODEL; LIFE-SPAN; PHOSPHORYLATION; OVEREXPRESSION; BIOGENESIS;
D O I
10.1007/s12035-023-03841-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mitochondrial transcription factor A (TFAM) is a mitochondrial protein encoded by nuclear genes and transported from the cytoplasm to the mitochondria. TFAM is essential for the maintenance, expression, and delivery of mitochondrial DNA (mtDNA) and can regulate the replication and transcription of mtDNA. TFAM is associated with the formation of mtDNA nucleomimetic structures, mtDNA repair, and mtDNA stability. However, the mechanism by which TFAM protects mtDNA is still being studied. This review provides a summary of the protective mechanism of TFAM on mtDNA including the discrete regulatory effects of TFAM acetylation and phosphorylation on mtDNA, the regulation of Ca2+ levels by TFAM to activate transcription in mitochondria, and the increased binding of TFAM to mtDNA damage hot spots. This review also discusses the association between TFAM and some neurodegenerative diseases.
引用
收藏
页码:4381 / 4390
页数:10
相关论文
共 50 条
[41]   An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases [J].
Zgorzynska, Emilia ;
Dziedzic, Barbara ;
Walczewska, Anna .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
[42]   Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases? [J].
Hu, Di ;
Liu, Zunren ;
Qi, Xin .
FRONTIERS IN NEUROSCIENCE, 2021, 15
[43]   Targeting Mitochondrial Defects to Increase Longevity in Animal Models of Neurodegenerative Diseases [J].
Casajus Pelegay, Ester ;
Puzzo, Francesco ;
Yilmazer, Acelya ;
Cagin, Umut .
REVIEWS ON BIOMARKER STUDIES OF METABOLIC AND METABOLISM-RELATED DISORDERS, 2019, 1134 :89-110
[44]   Mechanism of pyroptosis in neurodegenerative diseases and its therapeutic potential by traditional Chinese medicine [J].
Liao, Yanfang ;
Wang, Xue ;
Huang, Liting ;
Qian, Hu ;
Liu, Wei .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[45]   An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration [J].
Cassarino, DS ;
Bennett, JP .
BRAIN RESEARCH REVIEWS, 1999, 29 (01) :1-25
[46]   Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function [J].
Esteras, Noemi ;
Dinkova-Kostova, Albena T. ;
Abramov, Andrey Y. .
BIOLOGICAL CHEMISTRY, 2016, 397 (05) :383-400
[47]   The Protective Effect of Exercise in Neurodegenerative Diseases: The Potential Role of Extracellular Vesicles [J].
Fuller, Oliver K. ;
Whitham, Martin ;
Mathivanan, Suresh ;
Febbraio, Mark A. .
CELLS, 2020, 9 (10)
[48]   Mitochondrial TFAM as a Signaling Regulator between Cellular Organelles: A Perspective on Metabolic Diseases [J].
Koh, Jin-Ho ;
Kim, Yong-Woon ;
Seo, Dae-Yun ;
Sohn, Tae-Seo .
DIABETES & METABOLISM JOURNAL, 2021, 45 (06) :853-865
[49]   TRPM7 and its role in neurodegenerative diseases [J].
Sun, Yuyang ;
Sukumaran, Pramod ;
Schaar, Anne ;
Singh, Brij B. .
CHANNELS, 2015, 9 (05) :253-261
[50]   Rab11 and Its Role in Neurodegenerative Diseases [J].
Sultana, Pinky ;
Novotny, Jiri .
ASN NEURO, 2022, 14